Danaher Corporation (NYSE:DHR) It is one of the stocks that Jim Cramer placed under the microscope. Cramer argued it while highlighting the performance of medical care actions. He said:
“Some of these medical care actions already seem to play for you. I mean, Merck increased 7% today. He will return to the 180s.”
A black man who has a tablet analyzes the stock market data on a monitor. Photo by Tima Miroshnichenko in Pexels
Danaher Corporation (NYSE: DHR) develops medical products, life sciences, biotechnology and diagnosis, including bioprocessing technologies, laboratory equipment, genomic tools and clinical instruments. Cramer mentioned the action during the episode of July 24 and said:
“Now, we bought this at the beginning of 2022 … I expected the business to stabilize and the stock returned like this. But for one reason after another, Danaher never found its balance …
While we recognize DHR’s potential as an investment, we believe that certain AI actions offer greater upward potential and have less downward risk. If you are looking for an extremely undervalued action that also benefits significantly from the Trump era tariffs and the wave trend, see our free report on the The best short -term AI actions.
(Tagstotranslate) Danaher Corporation (T) Jim Cramer (T) Charity Trust (T) Medical care actions